Illumina’s NovaSeq series has been designed to allow a broad set of researchers to access next-generation sequencing technology and more easily conduct large-scale genomics projects with greater sample volumes, or more breadth and depth in the genome.
Read More
The test can help physicians identify women at increased risk for premature delivery as early as 19 weeks into the pregnancy.
Read More
The kit is intended to detect and differentiate the most common genetic risk variants responsible for thrombosis and embolisms.
Read More
The guidelines are designed to assist healthcare professionals in the diagnosis, treatment, and monitoring of patients with rheumatoid arthritis.
Read MoreThe test’s associated proprietary software is now cleared for the analysis of data from next-generation sequencing, as well as from qPCR.
Read More